• Login
    View Item 
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Research papers (Caprisa)
    • View Item
    •   ResearchSpace Home
    • Caprisa (Centre for the Aids programme of research in South Africa)
    • Research papers (Caprisa)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.

    Thumbnail
    View/Open
    Review (248.0Kb)
    Date
    2013
    Author
    Shey, Muki S.
    Kongnyuy, Eugene J.
    Alobwede, Samuel M.
    Wiysonge, Charles Shey.
    Metadata
    Show full item record
    Abstract
    The primary objective of this review was to evaluate the antiviral efficacy of co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection. The secondary objectives were to evaluate the safety and tolerability of the triple drug combination. We identified 15 potentially eligible studies, four of which met our inclusion criteria. Our findings indicate that co-formulated abacavirlamivudine-zidovudine remains a viable option for initiating antiretroviral therapy, especially in HIV-infected patients with pre-existing hyperlipidaemia and those who do not tolerate ritonavir.
    URI
    http://dx.doi.org/10.1002/14651858.CD005481.pub3.
    http://hdl.handle.net/10413/10180
    Collections
    • Research papers (Caprisa) [447]

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisorsTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsAdvisorsType

    My Account

    LoginRegister

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV